Here's 4 Marijuana Stocks To Focus On After Monday's Market Rout

Another down day on the marijuana stock market may have investors worried that the current correction has no end in sight. Long-term cannabis stock players, on the other hand, understand the dips and dives of a young market still gaining its footing. While most of the marijuana market sank on Monday, several weed stocks made substantial gains to beat out most of the competition.

Here are four marijuana stocks to focus on after Monday's market rout:

Innovative Industrial Properties, Inc.

new TradingView.widget(
{
"width": 770,
"height": 525,
"symbol": "NYSE:IIPR",
"interval": "D",
"timezone": "Etc/UTC",
"theme": "Light",
"style": "1",
"locale": "en",
"toolbar_bg": "#f1f3f6",
"enable_publishing": false,
"hide_top_toolbar": true,
"save_image": false,
"container_id": "tradingview_9069b"
}
);

Five days out from their fourth-quarter and full-year 2017 financial results and Innovative Industrial Properties, Inc. (NYSE:IIPR) finds themselves sitting atop a piling heap of pot stocks, comfortably making gains as competitors and industry peers struggle to define the term. While $2.3 million in revenues and just under $300,000 net income for the quarter are respectable, it is the company's dividends that should give marijuana stock investors pause to turn their heads. Innovative paid out a third consecutive dividend in the fourth quarter, $0.25 per share, which represents a 67 percent increase over the previous quarter’s dividend.

As the marijuana markets continued to decline on Monday, cannabis stock investors held strong on Innovative, holding out hope that 2018’s turnaround year would continue. As Seeking Alpha recently noted, their new ability to raise funds, combined with their push to diversify, makes this one weed stock to consider. Beating the market with a nine percent gain on Monday makes them a reliable marijuana stock to focus on come Tuesday’s opening bell.  

Axim Biotechnologies Inc.

new TradingView.widget(
{
"width": 770,
"height": 525,
"symbol": "OTC:AXIM",
"interval": "D",
"timezone": "Etc/UTC",
"theme": "Light",
"style": "1",
"locale": "en",
"toolbar_bg": "#f1f3f6",
"enable_publishing": false,
"hide_top_toolbar": true,
"save_image": false,
"container_id": "tradingview_bbae7"
}
);

When Axim Biotechnologies Inc. (OTC:AXIM) laid out their medical THC and CBD pipeline of drugs and clinical trials thirteen days ago, investors saw a global view of this weed stock’s capabilities laid out before them. Most notably, the company’s focus on CBD-based drugs and innovative drug delivery systems may be a driver for growth in the pharmaceutical industry. Investors know this pot stock’s focus has a considerable upside.

Cannabis stock shareholders need to look no further than Medical Marijuana Inc. (NASDAQOTH:MJNA) who owns a 40 percent stake in Axim; an investment which pushed Medical up from $0.23 per share to near $20 per share. Axim, as Motley Fool recently noted, “has been almost entirely responsible for pushing Medical Marijuana's equity higher over the trailing few quarters.”

Gaining over seven percent themselves this past Monday, Axim may seem like a steal in a pot stock market lacking any real prospects -- and truth be told, they just may be one.

Solis Tek Inc.

new TradingView.widget(
{
"width": 770,
"height": 525,
"symbol": "OTC:SLTK",
"interval": "D",
"timezone": "Etc/UTC",
"theme": "Light",
"style": "1",
"locale": "en",
"toolbar_bg": "#f1f3f6",
"enable_publishing": false,
"hide_top_toolbar": true,
"save_image": false,
"container_id": "tradingview_9b770"
}
);

Financial results had a hold on marijuana stock investors on Monday, as Solis Tek Inc. (OTCMKTS:SLTK) released their full-year results for 2017 earlier in the day. The self-described cannabis space technology innovator, developer, manufacturer, and distributor pulled in revenues of $8.98 million, a five percent increase over the previous year. Moreover, $2.5 million in new capital was raised to aid in their supply chain fulfillment and nutrient line automation.

Cannabis stock investors see promise in Solis Tek where once there stood chaos. Earlier this year, former company CEO Alan Lien returned, replacing ousted Executive Dennis Forchic, who was removed from his position by the Board of Directors. Modest gains on Monday still had the company in a better position than most weed stocks, making Solis Tek an even bet to ride out the market’s rut this week.

Freedom Leaf, Inc.

new TradingView.widget(
{
"width": 770,
"height": 525,
"symbol": "OTC:FRLF",
"interval": "D",
"timezone": "Etc/UTC",
"theme": "Light",
"style": "1",
"locale": "en",
"toolbar_bg": "#f1f3f6",
"enable_publishing": false,
"hide_top_toolbar": true,
"save_image": false,
"container_id": "tradingview_29f87"
}
);

Early last month Freedom Leaf, Inc. (OTCQB:FRLF) made some real headway into the CBD market when the company acquired the Irie CBD Product Line, a deal which included all assets, trademarks, formulating equipment, formulas, and products, according to a statement. The deal saw the company pay nearly $400,000 in cash and an additional $1.8 million in stock-- equivalent to $0.23 per share. Cannabis stock investors should dig deep when it comes to a company smart enough to enter this market.

It was a massive deal, one that included Earth Born, Inc., a California corporation; Earth Born, Inc., a Delaware corporation; Irie Living, a California nonprofit mutual benefit corporation, and Genesis Media Works, LLC, a Utah limited liability company doing business as “Terra’s Way,” “Irie Hemp Company,” and “Earth Born Botanicals”. With the company gaining over nine percent on Monday, the CBD market has made this marijuana stock a safe bet this week.

Add comment